Novel insulin sensitizers: pharmacogenomic aspects
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 3 (1) , 99-116
- https://doi.org/10.1517/14622416.3.1.99
Abstract
Thiazolidinediones (TZD, glitazones) are a new class of oral antidiabetic drugs which exert their insulin sensitizing action by stimulation of the nuclear transcription factor peroxisome proliferator-activated receptor gamma (PPAR-gamma). At present pioglitazone and rosiglitazone are available for clinical use. Different activation levels of PPAR-gamma and of co-factors determine the binding of PPAR-gamma to distinct target genes, which in turn regulates their transcriptional activity. TZD lower blood glucose levels, partly by influencing glucose transporters and the insulin-signaling pathway. In this review the molecular and cellular mechanisms as well as the metabolic effects of PPAR activation by TZD are discussed. Knowledge regarding the influence of genetic variations of PPAR-gamma on the effects of TZD is so far limited to in vitro studies. The results of these studies are reviewed.Keywords
This publication has 164 references indexed in Scilit:
- Involvement of P21Waf1/Cip1, P27Kip1, and P18Ink4c in Troglitazone–Induced Cell–Cycle Arrest in Human Hepatoma Cell LinesHepatology, 2001
- Effects of Troglitazone on Cellular Differentiation, Insulin Signaling, and Glucose Metabolism in Cultured Human Skeletal Muscle CellsBiochemical and Biophysical Research Communications, 2001
- Troglitazone and related compoundsLife Sciences, 2000
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationNew England Journal of Medicine, 1998
- The Antidiabetic Agent Thiazolidinedione Stimulates the Interaction between PPARγ and CBPBiochemical and Biophysical Research Communications, 1997
- Pioglitazone Improves Insulin Signaling Defects in Skeletal Muscle from Wistar Fatty (fa/fa) RatsBiochemical and Biophysical Research Communications, 1996
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- A transcriptional co-repressor that interacts with nuclear hormone receptorsNature, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994